Xiaofeng Wen
Liuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.
Journal: Infectious diseases and therapy
Published: July 17, 2023
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients.
Journal: Journal of clinical and translational hepatology
Published: October 11, 2022
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 study.
Journal: Journal of viral hepatitis
Published: June 28, 2021
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B.
Journal: Alimentary pharmacology & therapeutics
Published: June 04, 2021
Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial.
Journal: Journal of gastroenterology and hepatology
Published: October 11, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 02, 2020
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China.
Journal: Journal of clinical and translational hepatology
Published: July 30, 2019
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.
Journal: Journal of clinical and translational hepatology
Published: May 13, 2019
Significance of P53 and high mobility group box 1 protein in different levels of liver fibrosis in chronic hepatitis B
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: December 09, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026